Systemic Sclerosis
You have full text access to this OnlineOpen article
Cigarette smoking in patients with systemic sclerosis
Article first published online: 28 DEC 2010
DOI: 10.1002/art.30071
Copyright © 2011 by the American College of Rheumatology
Additional Information
How to Cite
Hudson, M., Lo, E., Lu, Y., Hercz, D., Baron, M., Canadian Scleroderma Research Group and Steele, R. (2011), Cigarette smoking in patients with systemic sclerosis. Arthritis & Rheumatism, 63: 230–238. doi: 10.1002/art.30071
Publication History
- Issue published online: 28 DEC 2010
- Article first published online: 28 DEC 2010
- Accepted manuscript online: 8 OCT 2010 09:23AM EST
- Manuscript Accepted: 28 SEP 2010
- Manuscript Received: 19 MAR 2010
Funded by
- Canadian Institutes of Health Research
- Scleroderma Society of Canada
- Cure Scleroderma Foundation
- Actelion Pharmaceuticals
- Pfizer Inc.
- New Investigator Award from the Canadian Institutes of Health Research
- Établissement de Jeunes Chercheurs award from the Fonds de la Recherche en Santé du Québec
REFERENCES
- 1. Scleroderma. In: HarrisEDJr, BuddRC, SergentJS, editors. Kelley's textbook of rheumatology. 7th ed. Philadelphia: Elsevier; 2005. p. 1279–308.
- 2, , , , . Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004; 53: 1730–5.
- 3, , , , , , et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol 2003; 38: 807–11.
- 4, , , , . The use of sliding time windows for the exploratory analysis of temporal effects of smoking histories on lung cancer risk. Stat Med 2000; 19: 2185–94.
- 5, . The ‘healthy smoker’: a phenomenon of health selection? Respiration 1990; 57: 137–44.
- 6, , , , . Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 688–93.
- 7, , , . Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum 2002; 46: 3312–6.
- 8, , , , Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985; 28: 759–67.
- 9, , , . Deterioration of lung function is associated with presence of IgM rheumatoid factor and smoking in patients with systemic sclerosis. Clin Rheumatol 2008; 27: 1053–6.
- 10, , , , . Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis. Rheumatol Int 2009; 29: 995–9.
- 11, , , . Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med 2006; 25: 4132–46.
- 12, . A comprehensive index for the modeling of smoking history in periodontal research. J Dent Res 2004; 83: 859–63.
- 13, , , , , , et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5.
- 14, , , . Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45.
- 15, The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40: 1984–91.
- 16, . Controlling for continuous confounders in epidemiologic research. Epidemiology 1997; 8: 429–34.
- 17R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2008.
- 18Health Canada. Smoking in Canada: an overview. 2003. URL: http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/tobac-tabac/research-recherche/stat/_ctums-esutc_fs-if/2003-smok-fum-eng.pdf.
- 19, , , , . Pulmonary function in scleroderma. Arthritis Rheum 1977; 20: 1071–9.
- 20, , , , , , et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007; 57: 318–26.
- 21, , , , , , et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol 2009; 15: 1690–701.
- 22, . Re: “Modeling smoking history: a comparison of different approaches” [letter]. Am J Epidemiol 2003; 158: 393.

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
